MENU
CVSI
AS OF
Feb 3 closing price
Price
$0.04
Change
-$0.00 (-0.00%)
Capitalization
8.05M
50 days until earnings call
Intraday BUY SELL Signals
+Compare
CVSI
Stock ticker: OTC
AS OF
Feb 3 closing price
Price
$0.04
Change
-$0.00 (-0.00%)
Capitalization
8.05M

CVSI CV Sciences, Inc. Forecast, Technical & Fundamental Analysis

CV Sciences Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol... Show more

CVSI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for CVSI with price predictions
Feb 03, 2026

Momentum Indicator for CVSI turns negative, indicating new downward trend

CVSI saw its Momentum Indicator move below the 0 level on January 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 106 similar instances where the indicator turned negative. In of the 106 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for CVSI turned negative on January 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 57 similar instances when the indicator turned negative. In of the 57 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVSI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CVSI entered a downward trend on February 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 79 cases where CVSI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

CVSI moved above its 50-day moving average on January 28, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CVSI advanced for three days, in of 215 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CVSI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.233) is normal, around the industry mean (29.792). P/E Ratio (2.505) is within average values for comparable stocks, (74.095). CVSI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.035). CVSI has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.029). P/S Ratio (0.561) is also within normal values, averaging (116.680).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CVSI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
CVSI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
9530 Padgett Street
Phone
+1 866 290-2157
Employees
43
Web
https://www.cvsciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LAWR3.75N/A
N/A
Robot Consulting Co Ltd
RMD251.41-3.33
-1.31%
ResMed
NMFC8.41-0.17
-1.98%
New Mountain Finance Corp
LEDS1.60-0.13
-7.57%
SemiLEDS Corp
ACIW39.52-3.93
-9.04%
ACI Worldwide

CVSI and Stocks

Correlation & Price change

A.I.dvisor tells us that CVSI and BLMH have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVSI and BLMH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVSI
1D Price
Change %
CVSI100%
-3.10%
BLMH - CVSI
21%
Poorly correlated
+15.90%
SHIEF - CVSI
20%
Poorly correlated
N/A
SWDCF - CVSI
20%
Poorly correlated
N/A
CWBHF - CVSI
7%
Poorly correlated
-10.94%
ELTP - CVSI
2%
Poorly correlated
-1.10%
More

Groups containing CVSI

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVSI
1D Price
Change %
CVSI100%
-3.10%
Pharmaceuticals: Generic
industry (214 stocks)
2%
Poorly correlated
-0.59%